News
Noise level: Our pick for the best quiet CPAP machine is the Luna G3, but you'll want to make sure that whichever model you ...
ResMed dominates healthcare devices with innovation, recurring revenues, and market leadership. See why we believe RMD stock ...
Resmed says that U.S. Customs and Border Protection has confirmed that its devices will continue to be exempt from tariffs ...
Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder. The company manufactures continuous ...
Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder. The company manufactures continuous ...
Resmed reported third quarter 2025 revenues of $1.3 billion, an increase of 8% over the same quarter the prior year.
A major Australian company has managed to secure a tariff exemption from the Trump Administration as the world waits to see ...
RBC Capital raised the firm’s price target on ResMed (RMD) to $255 from $247 and keeps a Sector Perform rating on the shares. The company’s Q3 ...
Piper Sandler lowered the firm’s price target on ResMed (RMD) to $248 from $260 and keeps a Neutral rating on the shares. The firm notes the ...
EPS of $2.37 on $1.29 billion in sales, citing strong global demand for sleep devices, plus a boost from tariff exemptions.
RESMED ($RMD) posted quarterly earnings results on Wednesday, April 23rd. The company reported earnings of $2.37 per share, missing estimates of $2.38 by $0.01. The ...
So CPAP reduces cardiovascular death rates by 55%. And this study wasn't small. This meta-analysis included over 1 million participants. So here at ResMed, we've known for decades that CPAP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results